Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Change in Accured Expenses: 2011-2024

Historic Change in Accured Expenses for Verastem (VSTM) over the last 14 years, with Dec 2024 value amounting to $8.0 million.

  • Verastem's Change in Accured Expenses rose 202.54% to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.4 million, marking a year-over-year increase of 697.24%. This contributed to the annual value of $8.0 million for FY2024, which is 172.26% up from last year.
  • Per Verastem's latest filing, its Change in Accured Expenses stood at $8.0 million for FY2024, which was up 172.26% from $2.9 million recorded in FY2023.
  • Verastem's Change in Accured Expenses' 5-year high stood at $8.0 million during FY2024, with a 5-year trough of -$5.0 million in FY2020.
  • Moreover, its 3-year median value for Change in Accured Expenses was $2.9 million (2023), whereas its average is $3.4 million.
  • As far as peak fluctuations go, Verastem's Change in Accured Expenses tumbled by 192.85% in 2020, and later surged by 560.50% in 2023.
  • Over the past 5 years, Verastem's Change in Accured Expenses (Yearly) stood at -$5.0 million in 2020, then surged by 135.93% to $1.8 million in 2021, then tumbled by 135.52% to -$638,000 in 2022, then spiked by 560.50% to $2.9 million in 2023, then skyrocketed by 172.26% to $8.0 million in 2024.